Inhibition of B16 melanoma growth and metastasis in C57BL mice by vaccination with a syngeneic endothelial cell line

• Published in: Journal of experimental & clinical cancer research Vol. 28; no. 1; p. 13
• Main Authors: Yoshiura, Kenta, Nishishita, Toshihide, Nakaoka, Takashi, Yamashita, Naohide, Yamashita, Naomi
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 31.01.2009; BioMed Central; BMC
• Subjects: Animals; Antibody Specificity; Cancer vaccines; Cancer Vaccines - immunology; Care and treatment; Cell Line; Cell Line, Tumor; Endothelial Cells - immunology; Health aspects; Immunotherapy; Immunotherapy, Adoptive - methods; Lung Neoplasms - immunology; Lung Neoplasms - prevention & control; Lung Neoplasms - secondary; Lung Neoplasms - therapy; Melanoma; Melanoma, Experimental - blood supply; Melanoma, Experimental - immunology; Melanoma, Experimental - pathology; Melanoma, Experimental - therapy; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic - immunology; Neovascularization, Pathologic - therapy; Prevention; Japan
• ISSN: 1756-9966; 0392-9078; 1756-9966
• DOI: 10.1186/1756-9966-28-13

Key role of angiogenesis in tumor growth and metastasis based on accumulating evidence and recent progress of immunotherapy have led us to investigate vaccine therapy targeting tumor angiogenesis. C57BL/6J mice were vaccinated with a syngeneic endothelial cell line Tpit/E by subcutaneous injection once a week. Prior to ninth vaccination, the mice were challenged with B16/F10 melanoma cells by subcutaneous inoculation on the back for the tumor growth model or by tail venous injection for the lung metastasis model. Development of subcutaneous tumor and lung metastasis was monitored by computed tomography scanning, which enabled accurate evaluation with the minimized sacrifice of mice. Vaccination with Tpit/E cells inhibited subcutaneous tumor growth and appearance of lung metastasis compared to control. Survival period was elongated in the Tpit/E vaccination in both of the two models. We also obtained hybridomas secreting specific antibodies to Tpit/E cells from a mouse vaccinated with the cells, indicating that specific immune response to the syngeneic endothelial cells was elicited. These results suggest that vaccination with an autologous endothelial cell line may be effective against melanoma.